financetom
Business
financetom
/
Business
/
What's Going On With Nikola Shares Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Nikola Shares Today?
Apr 4, 2024 6:35 AM

Nikola Corporation ( NKLA ) shares show premarket gain on Thursday following an 8.4% drop in yesterday’s regular session.

The Arizona-based truck and energy units operator said it has produced 43 and wholesaled 40 Class 8 Nikola ( NKLA ) hydrogen fuel cell electric vehicles for U.S. customers in the first quarter of 2024.

In addition, the Nikola ( NKLA ) team has commenced the return process for the BEV “2.0” trucks to customers, the company said in a press release.

“This includes not only the production and sale of our hydrogen fuel cell electric trucks but also the start of returns for our battery-electric trucks to customers,” said Nikola ( NKLA ) CEO Steve Girsky. 

However, in the press release the company confirmed that it has not completed its quarterly review process or the preparation of its financial statements for the first quarter ended March 31, 2024. 

The Nikola ( NKLA ) hydrogen fuel cell and battery-electric vehicles are assembled in Coolidge, Arizona.  

Earlier this month, the company was in the headlines for taking legal action against the company it sold the Badger electric pickup truck assets to last year.

Nikola ( NKLA ) sold its Badger electric pickup truck and powersports assets to EMBR Motors, a company created by television personality Dave “Heavy D” Sparks, best known as one half of the Diesel Brothers.

In a regulatory filing, Nikola ( NKLA ) said Sparks, attorney Cole Cannon and disgraced Nikola ( NKLA ) founder Trevor Milton subsequently launched a campaign to take over the company’s board after buying the assets, even though Sparks agreed that Milton would not be involved in any way.

Price Action: NKLA shares are trading higher by 7.64% to $0.96 premarket on the last check Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Municipal Bond Offerings This Week See High Flood Scores
Municipal Bond Offerings This Week See High Flood Scores
Oct 7, 2024
09:07 AM EDT, 10/07/2024 (MT Newswires) -- Multiple municipal bond offerings this week have a high exposure to climate risk, specifically high Flood Scores, according to ICE Climate Data. A $41 million offering from Sea Isle, N.J., records a Flood Score of 5.0 out of 5.0, ICE reports. Locations with a component Physical Climate Risk Score, which includes Flood, Wildfire...
Barnes Group to Be Taken Private by Apollo in $3.6 Billion Deal
Barnes Group to Be Taken Private by Apollo in $3.6 Billion Deal
Oct 7, 2024
09:05 AM EDT, 10/07/2024 (MT Newswires) -- Barnes Group ( B ) on Monday agreed to be acquired and taken private by funds managed by affiliates of Apollo Global Management ( APO ) in a deal that values the industrial company at about $3.6 billion. Barnes shareholders will receive $47.50 per share in cash. After completion of the deal, Barnes...
RTX Completes Testing of Barracuda Mine Neutralization System
RTX Completes Testing of Barracuda Mine Neutralization System
Oct 7, 2024
09:02 AM EDT, 10/07/2024 (MT Newswires) -- RTX's (RTX) Raytheon unit said Monday that it has recently conducted controlled environmental tests for its Barracuda Mine Neutralization System, which uses sonar and camera systems to locate and neutralize undersea mines. The company said the tests, which were conducted at the Naval Surface Warfare Center Carderock Division in Maryland, demonstrated the Barracuda...
Akebia Therapeutics Enters Multi-Year Supply Contract With U.S. Renal Care for Vafseo
Akebia Therapeutics Enters Multi-Year Supply Contract With U.S. Renal Care for Vafseo
Oct 7, 2024
09:05 AM EDT, 10/07/2024 (MT Newswires) -- Akebia Therapeutics ( AKBA ) said Monday it entered into a multi-year commercial supply contract with U.S. Renal Care dialysis, or USRC, centers. The contract allows USRC physicians to prescribe the company's drug, Vafseo, for dialysis patients when deemed clinically appropriate, with availability expected in January 2025. Vafseo received US Food and Drug...
Copyright 2023-2026 - www.financetom.com All Rights Reserved